Liberate Bio
2 employees
Bioinformatics
Seed · $31.0M
Company details
Team Size2
IndustryBioinformatics
Funding
Total raised
$31.0M
Last stage
Seed
Investors
Founders
Nessan Bermingham
Total raised
$31.0M
Last stage
Seed
Investors
Nessan Bermingham
Serial biotech entrepreneur and Operating Partner at Khosla Ventures; co-founder and founding CEO of Intellia Therapeutics.
Michael J. Mitchell
Assistant Professor of Bioengineering at the University of Pennsylvania; expert in lipid nanoparticle drug delivery.
Stephen Scully
Previously Principal Scientist at Intellia Therapeutics; expert in particle formulations for nucleic acid delivery.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.